ACM
CRDF icon

Aquatic Capital Management’s Cardiff Oncology CRDF Stock Holding History

Aquatic Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-700
Closed -$2K – 1256
2022
Q1 		$2K Sell
700
-7,300
-91% -$25.8K ﹤0.01% 958
2021
Q4 		$48K Buy
+8,000
New +$47.7K 0.09% 319

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Aquatic Capital Management's CRDF Position: Q2 2022 in Review

Aquatic Capital Management sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 700 shares — an estimated $2K sold.

Aquatic Capital Management first reported a position in CRDF in Q4 2021 and held it in 2 quarters. The position peaked at $48K in Q4 2021. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • Aquatic Capital Management reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 700 Cardiff Oncology shares in Q2 2022, an estimated $2K.
  • Aquatic Capital Management first reported a position in Cardiff Oncology in Q4 2021 and held it in 2 quarters.
  • Aquatic Capital Management's Cardiff Oncology position peaked at $48K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on Aquatic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.